Linvoseltamab, CAS 2408319-25-3

Product Description: Linvoseltamab is a bispecific antibody targeting to both BCMA (TNFRSF17) and CD3 epsilon. Linvoseltamab shows safety profile and encouraging efficacy in relapsed/refractory multiple myeloma (RRMM) models[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Linvoseltamab. IMGT/mAb-DB./[2]Lee H C, et al. LINKER-MM1 study: Linvoseltamab (REGN5458) in patients with relapsed/refractory multiple myeloma[J]. 2023.

CAS Number: 2408319-25-3

Molecular Weight: N/A

Compound Purity: 99.71

Research Area: Cancer

Solubility: 10 mM in DMSO/H2O

Target: CD3;TNF Receptor

• Artikelnummer: MEXHY-P9989-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9989-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated